Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
12/31/2003 | CN1463703A Nasal cavity preparation for treating long-term allergic reaction coryza |
12/31/2003 | CN1463698A Oral preparation compound containing Fudosteine |
12/31/2003 | CN1463610A Process for making liquorice tea |
12/31/2003 | CN1132819C 作为TNF-α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors |
12/31/2003 | CN1132620C Aseptic 'Shenmai' powder for injection and its preparing process |
12/31/2003 | CN1132611C Chinese medicine for treating chronic laryingitis and vocal fold node and process for preparing its granular medicine |
12/31/2003 | CN1132593C Mixture of white pepper and borneol and its application |
12/31/2003 | CN1132579C 脱乙氧羰基氯雷他定的无乳糖、非吸湿性及无水的药物组合物 De-ethoxycarbonyl loratadine lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions |
12/31/2003 | CA2491210A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
12/31/2003 | CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
12/31/2003 | CA2490626A1 Prodrug, medicinal utilization thereof and process for producing the same |
12/31/2003 | CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
12/31/2003 | CA2490082A1 Quinuclidine derivatives and pharmaceutical compositions containing the same |
12/31/2003 | CA2489813A1 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
12/31/2003 | CA2489528A1 Nasal compositions comprising a mucopolysaccharide and propylene glycol |
12/31/2003 | CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
12/31/2003 | CA2487346A1 Cannabinoid receptor agonists |
12/31/2003 | CA2464539A1 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
12/31/2003 | CA2445515A1 Transcription factor modulating compounds and methods of use thereof |
12/30/2003 | US6670473 Inhibitors of nitric oxide synthase (nos) |
12/30/2003 | US6670396 Aspirin-triggered lipid mediators |
12/30/2003 | US6670389 Laulimalide derivatives |
12/30/2003 | US6670381 Benzamide derivatives as thrombin inhibitors |
12/30/2003 | US6670379 Piperidine compounds for use as ccr-3 inhibitors |
12/30/2003 | US6670376 Aryl aniline β2 adrenergic receptor agonists |
12/30/2003 | US6670372 Aryl ether substituted imidazoquinolines |
12/30/2003 | US6670370 Cough suppression; reacting dextromethorphan with tannic acid |
12/30/2003 | US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
12/30/2003 | US6670364 Antagonists of MCP-1 function and methods of use thereof |
12/30/2003 | US6670358 Substituted thioacetamides |
12/30/2003 | US6670357 Antiinflammatory agents |
12/30/2003 | US6670349 Asthma |
12/30/2003 | US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders |
12/30/2003 | US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
12/30/2003 | CA2293621C 4-aminopyrrole(3,2-d) pyrimidines as neuropeptide y receptor antagonists |
12/30/2003 | CA2280940C Use of plant extract for inhibition of haemophilus influenzae |
12/30/2003 | CA2146723C Percutaneous absorption preparation |
12/25/2003 | WO2003105846A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
12/25/2003 | US20030237101 Stem cell factor; modulation of gene expression |
12/25/2003 | US20030236435 Synthesis of 2-alkylcysteine via substituted thiazoline ester |
12/25/2003 | US20030236434 Condensing cysteine with cabocyclic nitriles to form 2-arylthiazoline-4-carboxylic acid, then amidation, alkylation, hydrolyzing and optionally purifying to form 2-methylcysteine |
12/25/2003 | US20030236426 Synthesis of benzimidate from benzoic acid |
12/25/2003 | US20030236412 Cyclic AMP-specific phosphodiesterase inhibitors |
12/25/2003 | US20030236404 Synthesis of 2-alkylcysteine via phase transfer catalysis |
12/25/2003 | US20030236389 Proteins, polynucleotides encoding them and methods of using the same |
12/25/2003 | US20030236281 Quinoline derivatives(2) |
12/25/2003 | US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor |
12/25/2003 | US20030236272 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |
12/25/2003 | US20030236263 Chemical compounds |
12/25/2003 | US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
12/25/2003 | US20030236244 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction |
12/25/2003 | US20030236238 Respiratory system disorders; asthma; stable powder form of formoterol; storage stability |
12/25/2003 | US20030236230 Comprises 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring; for controlling weight gain in a human or higher mammal |
12/25/2003 | US20030235900 Anticancer agents |
12/25/2003 | US20030235616 Pharmaceutical pills comprising drugs such as non-steroidal antiinflammatory agents, and cores surrounded by shells, having apertures for timed or sustained drug delivery |
12/25/2003 | US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof |
12/25/2003 | US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation |
12/25/2003 | US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha |
12/24/2003 | WO2003106462A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
12/24/2003 | WO2003106455A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators |
12/24/2003 | WO2003106451A1 Substituted diaminopyrimidines |
12/24/2003 | WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
12/24/2003 | WO2003106420A1 2,5-disubstituted 3-mercaptopentanoic acid |
12/24/2003 | WO2003106403A1 Carboxamides derivatives |
12/24/2003 | WO2003105908A2 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
12/24/2003 | WO2003105907A2 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
12/24/2003 | WO2003105893A2 Probiotic therapies |
12/24/2003 | WO2003105885A1 Novel method of screening |
12/24/2003 | WO2003105884A1 Use of shp-1 for the therapy of asthma |
12/24/2003 | WO2003105872A1 Anti-spasmodic comprising xenon |
12/24/2003 | WO2003105859A1 Powdery respiratory tonic composition |
12/24/2003 | WO2003105856A1 Combination of azelastine and steroids |
12/24/2003 | WO2003105800A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
12/24/2003 | WO2003105776A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
12/24/2003 | WO2003105775A2 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
12/24/2003 | WO2003105771A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
12/24/2003 | WO2003090662A3 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease |
12/24/2003 | WO2003086396A9 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
12/24/2003 | WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
12/24/2003 | WO2003084519A3 Aerosol formulation for inhalation comprising a tiotropium salt |
12/24/2003 | WO2003077892A3 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for treating ang ii-mediated diseases |
12/24/2003 | WO2003075926A8 Use of proton pump inhibitors for the treatment of airway disorders |
12/24/2003 | WO2003075827A3 Use of mycobacterium w in the treatment of asthama(obstructive lung disease) |
12/24/2003 | WO2003075824A3 Process of manufacturing pharmaceutical composition useful for management of tuberculosis |
12/24/2003 | WO2003074025A3 Pressurised metered dose inhalers containing solutions of beta-2 agonists |
12/24/2003 | WO2003070914A3 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
12/24/2003 | WO2003070182A3 Sodium channel blockers |
12/24/2003 | WO2003070153A3 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives |
12/24/2003 | WO2003068760A3 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
12/24/2003 | WO2003068224A3 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases |
12/24/2003 | WO2003065044A8 Diagnostics and therapeutics for diseases associated with gpr72 |
12/24/2003 | WO2003064685A3 Genetic polymorphisms in the preprotachykinin gene |
12/24/2003 | WO2003063800A3 8-heteroaryl xanthine adenosine a2b receptor antagonists |
12/24/2003 | WO2003053361A3 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE |
12/24/2003 | WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
12/24/2003 | WO2003035137A3 Method and apparatus for dispensing inhalator medicament |
12/24/2003 | WO2002018540A3 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
12/24/2003 | CN1462755A Method for distilling active protein liquid of scorpion |
12/24/2003 | CN1462631A Medicine combination containing white atractylodes rhizome and its preparation method |
12/24/2003 | CN1462627A Chinese herbal medicine prescription for prevention and treatment of atypical pneumonia |